Skip to main content

Treatment of AR+/ER+/HER2- Metastatic Breast Cancer  

Translating Science Into New Treatments

The Revive Research Institute brings innovation to today’s oncology development to help manage trial complexities and increase the quality of the data collected in clinical trials. Many of the clinical researches performed at Revive has resulted in treatment breakthroughs and new standards of care for patients with different diseases. 

Breast cancer is the most commonly diagnosed cancer in women with an estimated 284,200 new cases and 44,130 deaths expected for 2021. With resistance developing to conventional endocrine therapies, there is a dire need for alternative treatment approaches. 

With over 20 research trials currently being conducted on our oncology sites, the Revive Research Institute is dedicated to working on the most promising novel therapies to change the way how we treat and diagnose cancer patients. We’re conducting a clinical research trial on an investigational drug for the treatment of metastatic breast cancer. 

If you’ve been diagnosed with metastatic breast cancer or have been failed by conventional treatments, consider joining our clinical trial. 

Participation Criteria:

  • Diagnosed with Metastatic Breast Cancer. 
  • Must be 18 years or older. 
  • Be willing to comply with study-related procedures. 
  • Additional Criteria may apply. 

Revive is committed to pioneering progress in cancer management and patient care. Qualified research participants may receive financial compensation for their time and travel, study-related medical evaluations, and investigative study medication at no cost.

Please provide YOUR contact information only.
For more info, please visit Privacy Policy.

If you require any further information, feel free to contact us at 248-564-1485.

Close Menu

Revive Research Institute, Inc.

28270 Franklin Road
Southfield, MI

T: 248-564-1485